Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Methylone

Is Methylone legal in United Kingdom?

Also known as: bk-MDMA

Confirmed against a primary sourceVerified October 3, 2026
Legal status
Controlled as a Class B drug through a generic definition. It is not named in Schedule 2 to the Misuse of Drugs Act 1971; Part II, paragraph 1(aa) reaches it, which covers any compound, not being bupropion, cathinone, diethylpropion or pyrovalerone, structurally derived from 2-amino-1-phenyl-1-propanone, which is cathinone, by the modifications the paragraph lists, inserted on 16 April 2010 by the Misuse of Drugs Act 1971 (Amendment) Order 2010, S.I. 2010/1207, among them «by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;» and «by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.» Methylone is 3,4-methylenedioxy-N-methylcathinone: cathinone with a methylenedioxy bridge, an alkylenedioxy, on the phenyl ring and a methyl on the nitrogen. It is the cathinone counterpart of MDMA, which is Class A under a different paragraph, and the class follows the paragraph, so methylone is Class B. Section 2(1)(b) of the Act provides that «the expressions “Class A drug”, “Class B drug” and “Class C drug” mean any of the substances and products for the time being specified respectively in Part I, Part II and Part III of that Schedule». Schedule 2 was read as in force on 2 October 2026 in the legislation.gov.uk revised text, which records no known outstanding effects and incorporates S.I. 2024/1361, in force 15 January 2025; Schedule 2 moves by Order in Council under section 2(2), so this does not rule out a later amendment.
Consequences if caught
Capital exposure: none. No provision of the Misuse of Drugs Act 1971, of the Customs and Excise Management Act 1979 or of the Psychoactive Substances Act 2016 provides a death sentence; the highest punishment in Schedule 4 to the 1971 Act is imprisonment for life. It is not named in Schedule 2. This row is Class B, so the Class B drug involved column of Schedule 4 to the 1971 Act governs. Possession, section 5(2), carries on indictment «5 years or a fine, or both.» Tried summarily, Class B possession carries «3 months or £2,500, or both.» Possession with intent to supply, section 5(3), supplying or offering to supply, section 4(3), and production, section 4(2), each carry on indictment «14 years or a fine, or both.» Part I of Schedule 2, paragraph 6, adds to Class A «Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.» As the text reads, a preparation of this row designed for administration by injection is therefore a Class A drug, and the Class A column applies to it: «7 years or a fine, or both.» for possession and «Life or a fine, or both.» for supply, production and possession with intent, on indictment. This cell makes no claim about which products are so designed. Sale has no offence of its own: selling is supplying under section 4(3), and trafficking is not a separate offence in the Act, being concerned in another person's supply falling under section 4(3)(b) and (c). Importation and exportation are prohibited by section 3(1) and prosecuted as customs offences under sections 50(3), 68(2) and 170(2) of the Customs and Excise Management Act 1979, which Schedule 1 to that Act punishes for this class «to a penalty of any amount, or to imprisonment for a term not exceeding 14 years, or to both». Cultivation falls under production, because section 37(1) defines producing as «producing it by manufacture, cultivation or any other method». Use is not itself an offence: the Act reaches the user through possession, and its only offence of use is smoking or otherwise using prepared opium under section 9. An occupier who knowingly permits production or supply on premises commits the section 8 offence, also 14 years on indictment. The Act sets no quantity threshold and no statutory presumption of intent to supply; on indictment the fine has no stated maximum and runs with imprisonment or alone, because every band reads «or a fine, or both». No administrative disposal attaches by statute: the penalty notice table in section 1 of the Criminal Justice and Police Act 2001, which applies in England and Wales, lists possession only of cannabis, cannabinol and its derivatives, and khat. Section 28 gives a defence of lack of knowledge; under section 28(3) a belief that it was a different controlled drug is no defence unless, had it been that drug, no offence would have been committed. The Psychoactive Substances Act 2016 does not reach it: section 2(1) of that Act confines a psychoactive substance to one that «is not an exempted substance (see section 3).» and Schedule 1 exempts «Controlled drugs (within the meaning of the Misuse of Drugs Act 1971).» The 1971 Act is therefore read first and governs alone.
If prescribed or medical
In England, Wales and Scotland the Misuse of Drugs Regulations 2001 place it in Schedule 1, under its paragraph 1(m), the matching cathinone definition. The patient possession authority in regulation 10(2) reaches only «a person may have in his possession any drug specified in Schedule 2, 3 or Part I of Schedule 4 for administration for medical, dental or veterinary purposes in accordance with the directions of a practitioner», so a Schedule 1 drug has no prescription route; apart from the regulation 6 authorities for police, customs officers, carriers and forensic laboratories acting in their duties, production, supply and possession are lawful only under a Home Office licence under regulation 5. On Northern Ireland the sources point two ways, and both are quoted. legislation.gov.uk tags every provision of the 2001 Regulations with the extent E+W+S+N.I. 45 such tags in its XML, while the Regulations themselves carry no extent clause; against that tag, their amending Regulations of 2023 and 2024 each state «These Regulations extend to England and Wales and Scotland.», and the 2026 temporary class drug order applies the two codes separately, saying «The Misuse of Drugs Regulations 2001 apply to the substances and products listed in the Schedule to this Order as if those substances and products were specified in Schedule 1 to those Regulations.» and «The Misuse of Drugs Regulations (Northern Ireland) 2002 apply to the substances and products listed in the Schedule to this Order as if those substances and products were specified in Schedule 1 to those Regulations.» Northern Ireland has its own Misuse of Drugs Regulations (Northern Ireland) 2002, S.R. 2002 No. 1. The legislation.gov.uk text of those Regulations states «There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Misuse of Drugs Regulations (Northern Ireland) 2002.», so the Northern Ireland schedule for this row is not given here.
Documentation
The Home Office page Take medicine in or out of the UK, read at https://www.gov.uk/travelling-controlled-drugs on 2 October 2026, states «You cannot bring schedule 1 drugs into the UK without a licence. Licences for schedule 1 drugs are limited to research or other special purposes.» and «You cannot use a Schengen Certificate to bring schedule 1 drugs into the UK.» No prescription, letter or certificate makes carrying it lawful.
Primary sources
  • Misuse of Drugs Act 1971, ss. 2 to 8, 28 and 37 and Schedules 2 and 4, Part II para. 1(aa), inserted by S.I. 2010/1207
  • legislation.gov.uk
  • read on 2 October 2026 as the legislation.gov.uk revised text, which records no known outstanding effects
  • Misuse of Drugs Regulations 2001, S.I. 2001/3998, regs. 4, 5 and 10 and Schedule 1 para. 1(m)
  • legislation.gov.uk
  • Customs and Excise Management Act 1979, ss. 50, 68 and 170 and Schedule 1
  • legislation.gov.uk
  • Home Office, Take medicine in or out of the UK
  • gov.uk
  • S.I. 2024/1361 read as made on 2 October 2026
  • legislation.gov.uk
  • Contains public sector information licensed under the Open Government Licence v3.0

Court records

The National Archives declined the transactional licence on 22 September 2026.

Source checked Find Case Law, The National Archives · 2026-08-26

Methylone in related jurisdictions

Other substances confirmed in United Kingdom

Same substance, other countries